Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone versus remifentanil for analgesia in invasively ventilated ICU patients
ChiCTR2500095714Phase 4Not yet recruiting
- Sponsor
- Fushun County People's Hospital
- Start
- Jan 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxycodone, remifentanil and midazolam in pain and agitation (2 arms), sponsored by Fushun County People's Hospital. Primary endpoints: Percentage of time at target analgesia depth, Dose required to achieve target analgesia and 2 more. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
oxycodoneremifentanilmidazolam
03
Conditions
painagitation
Beyond the preview
Go deeper on ChiCTR2500095714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095714.